Skip to main content
Back to SBI Investment

SBI Investment's Pharmaceutical Portfolio

Browse 9 Pharmaceutical companies funded by SBI Investment. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
9
Total Funding in Pharmaceutical
$131.8M

Pharmaceutical Portfolio Companies (9)

Export
BiotechnologyManagement ConsultingPharmaceuticalTherapeutics

GAIA BioMedicine is a biopharmaceutical company that specializes in innovative cell therapies and immunotherapies for treating solid tumors.

Fukuoka, Japan
September 2021
$11.9M
Series B

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyMachine LearningMedicalPharmaceutical

Molcure is a high-speed, high-quality, high-variation antibody screening & design system combining biology, automation and bioinformatics

Tokyo, Japan
August 2021
$7.3M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsMedicalPharmaceutical

Alivexis is a biotechnology company that engages in the research and development of custom medicine for the pharmaceutical industry.

Minato, Japan
March 2022
$20.4M
Series C

Founder Contacts

30,000+ verified contacts

MedicalPharmaceuticalTherapeutics

Alpha Fusion is a clinical research company that focuses on cancer treatment through the design and development of radiopharmaceuticals.

Osaka, Japan
October 2024
$6.9M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Mepsgen is a biotechnology research organization that focuses on pharmaceutical services and drug development.

Seoul, South Korea
November 2024
$14.9M
Series C

Founder Contacts

30,000+ verified contacts

MedicalPharmaceutical

UPPTHERA is a pharmaceutical company that specializes in drug development using targeted protein degradation technology.

Incheon, South Korea
May 2022
$21.9M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaPharmaceutical

Inibio is a biomedical firm that specializes in medical aesthetics and develops botox from organic components.

Gyeongju, South Korea
February 2022
$34.7M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyCosmeticsHealth CarePharmaceutical

ExoCoBio has been developing innovative therapeutics as well as cosmetic products based on stem cell-derived exosomes.

Seoul, South Korea
August 2020
$9.3M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyNursing and Residential CarePharmaceutical

GlyTech is a responsibility of the company to protect personal information in its business activities.

Kyoto, Japan
July 2020
$4.6M
Series Unknown

Founder Contacts

30,000+ verified contacts

Explore SBI Investment's Full Portfolio

View all companies funded by SBI Investment across every industry and funding stage.

View Full SBI Investment Portfolio